Panmyk (Fluprednidene Acetate, Miconazole Nitrate)

Fluprednidene acetate, the active ingredient in Panmyk, is a topical corticosteroid presented as a strength/form for topical use. It treats inflammatory skin conditions and fungal infections in adults and children. GNH USA supplies Panmyk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Panmyk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Panmyk combines a corticosteroid and an antifungal to address mixed inflammatory and fungal skin disorders.

- Dermatophytosis: reduces fungal growth and inflammation, promoting lesion clearance. - Seborrheic dermatitis: alleviates scaling and redness through anti‑inflammatory and antifungal actions. - Atopic dermatitis: diminishes itching and erythema in inflamed skin. - Psoriasis: helps control plaque formation and associated inflammation. - Mixed fungal and inflammatory skin conditions: provides combined antimicrobial and anti‑inflammatory effects.

Potential adverse reactions may occur with topical application of Panmyk.

Common Side Effects: - Burning sensation - Itching - Mild skin irritation - Redness at the application site - Dryness - Peeling

Serious or Rare Side Effects: - Contact dermatitis - Skin atrophy - Secondary bacterial infection - Hypersensitivity reactions - Systemic corticosteroid effects (rare with limited use) - Severe allergic reactions such as anaphylaxis.

When using Panmyk, follow these safety considerations:

- Avoid prolonged use: limit to the duration prescribed by a healthcare professional. - Do not apply to broken skin: application on open wounds may increase systemic absorption. - Use cautiously in children: children may be more susceptible to systemic effects. - Monitor for signs of infection: discontinue if bacterial infection develops. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Panmyk may interact with other topical or systemic agents.

Major Interactions (Avoid): - Concurrent use with other potent corticosteroids: increased risk of skin atrophy. - Use with systemic antifungal therapy: may alter systemic exposure to miconazole.

Moderate Interaction ( Monitor Closely): - Co‑application with wound healing agents such as hydro­hyd hydro‑  . -  .

--- ---